Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained-release dosage forms of ruxolitinib

Sustained-release dosage forms of ruxolitinib

US Patent 11896717 · Granted Feb 13, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing regimen for the treatment of PI3K related disorders2025
Topical formulation for a JAK inhibitor2025
Topical formulation for a JAK inhibitor2025
User context-based enterprise search with multi-modal interaction2024
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2024
Sustained release dosage forms for a JAK1 inhibitor2024
Sustained release dosage forms for a JAK1 inhibitor2024
Multiple semantic hypotheses for search query intent understanding2024
Modeling method and apparatus for diagnosing ophthalmic disease based on artific2023
Methods of treating cancer with an FGFR inhibitor2023
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2023
Topical formulation for a JAK inhibitor2023